These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 32806313)

  • 1. Recent advances in tumor microenvironment associated therapeutic strategies and evaluation models.
    Haider T; Sandha KK; Soni V; Gupta PN
    Mater Sci Eng C Mater Biol Appl; 2020 Nov; 116():111229. PubMed ID: 32806313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the Potential of Nanotherapeutics in Targeting Tumor Microenvironment for Cancer Therapy.
    Muntimadugu E; Kommineni N; Khan W
    Pharmacol Res; 2017 Dec; 126():109-122. PubMed ID: 28511988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smart Nanotherapeutic Targeting of Tumor Vasculature.
    Li Z; Di C; Li S; Yang X; Nie G
    Acc Chem Res; 2019 Sep; 52(9):2703-2712. PubMed ID: 31433171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor Microenvironment Sensitive Nanocarriers for Bioimaging and Therapeutics.
    Park H; Saravanakumar G; Kim J; Lim J; Kim WJ
    Adv Healthc Mater; 2021 Mar; 10(5):e2000834. PubMed ID: 33073497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiogenesis as a hallmark of solid tumors - clinical perspectives.
    Majidpoor J; Mortezaee K
    Cell Oncol (Dordr); 2021 Aug; 44(4):715-737. PubMed ID: 33835425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current advances in nanoformulations of therapeutic agents targeting tumor microenvironment to overcome drug resistance.
    Fakhri S; Moradi SZ; Faraji F; Farhadi T; Hesami O; Iranpanah A; Webber K; Bishayee A
    Cancer Metastasis Rev; 2023 Sep; 42(3):959-1020. PubMed ID: 37505336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.
    Zhao Y; Adjei AA
    Oncologist; 2015 Jun; 20(6):660-73. PubMed ID: 26001391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving drug delivery to solid tumors: priming the tumor microenvironment.
    Khawar IA; Kim JH; Kuh HJ
    J Control Release; 2015 Mar; 201():78-89. PubMed ID: 25526702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Advances and Strategies in Tumor Vasculature Targeted Nano-Drug Delivery Systems.
    Ying M; Chen G; Lu W
    Curr Pharm Des; 2015; 21(22):3066-75. PubMed ID: 26027578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment.
    Yang M; Li J; Gu P; Fan X
    Bioact Mater; 2021 Jul; 6(7):1973-1987. PubMed ID: 33426371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Celecoxib normalizes the tumor microenvironment and enhances small nanotherapeutics delivery to A549 tumors in nude mice.
    Zhang B; Jin K; Jiang T; Wang L; Shen S; Luo Z; Tuo Y; Liu X; Hu Y; Pang Z
    Sci Rep; 2017 Aug; 7(1):10071. PubMed ID: 28855534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nano drug delivery system reconstruct tumour vasculature for the tumour vascular normalisation.
    Liang Q; Zhou L; Li Y; Liu J; Liu Y
    J Drug Target; 2022 Feb; 30(2):119-130. PubMed ID: 33960252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting tumor microenvironment and metastasis in children with solid tumors.
    Wessel KM; Kaplan RN
    Curr Opin Pediatr; 2022 Feb; 34(1):53-60. PubMed ID: 34812775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
    Gacche RN; Meshram RJ
    Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges.
    Fukumura D; Kloepper J; Amoozgar Z; Duda DG; Jain RK
    Nat Rev Clin Oncol; 2018 May; 15(5):325-340. PubMed ID: 29508855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune cell-camouflaged surface-engineered nanotherapeutics for cancer management.
    Jain N; Shahrukh S; Famta P; Shah S; Vambhurkar G; Khatri DK; Singh SB; Srivastava S
    Acta Biomater; 2023 Jan; 155():57-79. PubMed ID: 36347447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic targets of multiple angiogenic factors for the treatment of cancer and metastasis.
    Cao Y; Liu Q
    Adv Cancer Res; 2007; 97():203-24. PubMed ID: 17419947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving delivery of antineoplastic agents with anti-vascular endothelial growth factor therapy.
    Yang AD; Bauer TW; Camp ER; Somcio R; Liu W; Fan F; Ellis LM
    Cancer; 2005 Apr; 103(8):1561-70. PubMed ID: 15754332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced permeability and retention of macromolecular drugs in solid tumors: a royal gate for targeted anticancer nanomedicines.
    Greish K
    J Drug Target; 2007; 15(7-8):457-64. PubMed ID: 17671892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor angiogenesis and accessibility: role of vascular endothelial growth factor.
    Jain RK
    Semin Oncol; 2002 Dec; 29(6 Suppl 16):3-9. PubMed ID: 12516032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.